Awards/COOPERATIVE AGREEMENT (B)

$82,511,281

Department of Health and Human Services·National Institutes of Health

to MAYO CLINIC

biotechexpiredONGOING · MOD OF 2019 CONTRACT

WORK BEGAN2019-09-15·LATEST ACTION2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_U19AG063911_075

Award description

ARTFL LEFFTDS LONGITUDINAL FRONTOTEMPORAL LOBAR DEGENERATION (ALLFTD)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds longitudinal research on frontotemporal lobar degeneration through a cooperative agreement with Mayo Clinic.

Sub-sectors

nih-research-grantsneurodegenerative-diseaselongitudinal-study

Why this matters

Addresses a rare but devastating neurodegenerative disease with limited treatment options; advances understanding of disease progression and potential therapeutics.

Supply-chain signal

Drives demand for biomarker assays, neuroimaging services, and clinical research infrastructure at academic medical centers.

U.S.–China competition angle

Neurodegenerative disease research is a competitive area; U.S. leadership in FTD understanding supports pharmaceutical innovation and clinical trial leadership.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002251.

Period of performance

Start

2019-09-15

End

2025-09-14

Status

expired246 days ago

Recipient

MAYO CLINIC

UEI Y2K4F9RPRRG7

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_U19AG063911_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.